MediLink Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
190
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$70M
- Investors
-
9
MediLink Therapeutics General Information
Description
Developer of antibody-drug conjugates (ADC) based in China. The company focuses on providing patients with ADC therapeutics that combat cancer while sparing healthy cells, keeping patients healthy while under treatment.
Contact Information
Website
www.medilinkthera.comCorporate Office
- Room A1-401
- No. 412, Bio-Industrial Park
- Suzhou, Jiangsu
- China
Corporate Office
- Room A1-401
- No. 412, Bio-Industrial Park
- Suzhou, Jiangsu
- China
MediLink Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 01-Mar-2022 | $70M | Completed | Clinical Trials - Phase 2 | ||
| 3. Early Stage VC | 20-Feb-2022 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A2) | 05-Mar-2021 | $41M | $41M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC (Series A1) | 13-Dec-2020 | Completed | Pre-Clinical Trials |
MediLink Therapeutics Comparisons
Industry
Financing
Details
MediLink Therapeutics Competitors (9)
One of MediLink Therapeutics’s 9 competitors is Oxford Biotherapeutics, a Private Equity-Backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxford Biotherapeutics | Private Equity-Backed | Oxford, United Kingdom | ||||
| Abeona Therapeutics | Corporation | Cleveland, OH | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Ironwood Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| ADC Therapeutics | Formerly VC-backed | Epalinges, Switzerland |
MediLink Therapeutics Signals
MediLink Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Highlight Capital | Venture Capital | Minority | ||
| Legend Capital | Venture Capital | Minority | ||
| LYFE Capital | PE/Buyout | Minority | ||
| Xiamen C&D Corporation | Corporation | Minority | ||
| FirstLight Capital (Beijing) | PE/Buyout | Minority |
MediLink Therapeutics Investments (1)
MediLink Therapeutics’s most recent deal was a Corporate Asset Purchase with SinoMab Bioscience (Property and Manufacturing Facility in Suzhou, China) for . The deal was made on 06-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SinoMab Bioscience (Property and Manufacturing Facility in Suzhou, China) | 06-Jul-2026 | Corporate Asset Purchase |
MediLink Therapeutics FAQs
-
When was MediLink Therapeutics founded?
MediLink Therapeutics was founded in 2020.
-
Where is MediLink Therapeutics headquartered?
MediLink Therapeutics is headquartered in Suzhou, China.
-
What is the size of MediLink Therapeutics?
MediLink Therapeutics has 190 total employees.
-
What industry is MediLink Therapeutics in?
MediLink Therapeutics’s primary industry is Drug Discovery.
-
Is MediLink Therapeutics a private or public company?
MediLink Therapeutics is a Private company.
-
What is the current valuation of MediLink Therapeutics?
The current valuation of MediLink Therapeutics is .
-
What is MediLink Therapeutics’s current revenue?
The current revenue for MediLink Therapeutics is .
-
How much funding has MediLink Therapeutics raised over time?
MediLink Therapeutics has raised $111M.
-
Who are MediLink Therapeutics’s investors?
Highlight Capital, Legend Capital, LYFE Capital, Xiamen C&D Corporation, and FirstLight Capital (Beijing) are 5 of 9 investors who have invested in MediLink Therapeutics.
-
Who are MediLink Therapeutics’s competitors?
Oxford Biotherapeutics, Abeona Therapeutics, CytomX Therapeutics, Ironwood Pharmaceuticals, and ADC Therapeutics are some of the 9 competitors of MediLink Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process